首页> 中文期刊> 《现代肿瘤医学》 >miR-26a通过调控E2F7、Myc抑制乳腺癌MDA-MB-231细胞的增殖和迁移能力

miR-26a通过调控E2F7、Myc抑制乳腺癌MDA-MB-231细胞的增殖和迁移能力

         

摘要

目的:研究miR-26a对乳腺癌MDA-MB-231细胞增殖和迁移能力的影响,并分析miR-26a调控增殖与迁移的可能机制.方法:应用实时荧光定量PCR法(QPCR)检测乳腺癌细胞系和正常乳腺上皮细胞中miR-26a的表达水平,并检测三阴型乳腺癌组织及相应正常乳腺组织中miR-26a与E2F7 mRNA的表达水平.应用脂质体介导的方法,以miR-26a mimics与E2F7 siRNA瞬时转染MDA-MB-231细胞,实时荧光定量PCR法检测miR-26a表达水平,Western blot法检测E2F7、Myc蛋白的表达水平.MTT法检测MDA-MB-231细胞的增殖能力,划痕实验检测MDA-MB-231细胞迁移能力.结果:乳腺癌细胞中miR-26a的表达水平均低于正常乳腺细胞MCF-10A,且三阴型乳腺癌细胞表达水平降低最明显.三阴型乳腺癌组织中miR-26a相对于正常乳腺组织表达减低,而E2F7 mRNA表达则显著升高.miR-26a mimics转染后miR-26a表达水平显著升高,miR-26a过表达可抑制E2F7、Myc蛋白的表达;E2F7 siRNA转染后E2F7表达水平减低,Myc蛋白表达亦减低.MTT实验结果示miR-26a过表达可抑制MDA-MB-231细胞增殖,划痕实验示miR-26a过表达可抑制乳腺癌MDA-MB-231细胞迁移能力.结论:miR-26a可能通过抑制E2F7、Myc 调控乳腺癌MDA-MB-231细胞的增殖与迁移能力.%Objective:To investigate the effect of miR-26a on proliferation and migration of breast cancer MDA-MB-231 cells,then to explore its possible mechanism.Methods:The miR-26a and E2F7 expression of breast cancer cell lines,normal breast epithelial cell,triple negative breast cancer tissues and adjacent normal breast tissues were detected by using Real-time PCR(QPCR).Transient transfection of miR-26a mimics and E2F7 siRNA to MDA-MB-231 cells were mediated by liposome.The miR-26a expression of MDA-MB-231 cell was detected by Real-time PCR,and the expression of E2F7 and Myc protein was detected by Western blot.The proliferation and migration ability were assessed by MTT and wound healing assay respectively.Results:The miR-26a levels of breast cancer cell lines were lower than that of normal breast cell MCF-10A,particularly triple negative breast cancer cell lines.Besides,the miR-26a expression of triple negative breast cancer tissues was inhibited compared to that of adja-cent normal breast tissues,while the E2F7 mRNA expression was elevated significantly.The miR-26a expression of MDA-MB-231 cell was elevated significantly after miR-26a mimics transfection.The overexpression of miR-26a decreased the expression of E2F7 and Myc protein,and the knockdown of E2F7 also decreased the expression of Myc.The miR-26a inhibited the proliferation and migration ability of MDA-MB-231 cells according to MTT and wound healing assay results.Conclusion:The miR-26a inhibited proliferation and migration ability of MDA -MB -231 cells via possible mechanism of E2F7 and Myc repression.

著录项

  • 来源
    《现代肿瘤医学》 |2018年第13期|1975-1979|共5页
  • 作者单位

    西安交通大学医学院第一附属医院呼吸内科,陕西 西安 710061;

    邹城市人民医院血液内分泌科,山东 邹城 273500;

    西安交通大学医学院第一附属医院呼吸内科,陕西 西安 710061;

    西安交通大学医学院第一附属医院呼吸内科,陕西 西安 710061;

    西安交通大学医学院第一附属医院呼吸内科,陕西 西安 710061;

    西安交通大学医学院第一附属医院胸外二科,陕西 西安 710061;

  • 原文格式 PDF
  • 正文语种 chi
  • 中图分类 乳腺肿瘤;
  • 关键词

    三阴型乳腺癌; miR-26a; E2F7; Myc; 增殖; 迁移;

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号